Loading...
Loading...
CDC PLACES (2023, crude) estimates 13.6% of adults in Savannah have diagnosed diabetes — 1.6 points above the U.S. 12% figure. Census population 147,780. Georgia Medicare wound biologics: Palmetto GBA (JJ). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Savannah clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Savannah storefront.
Growth Factor Therapy for Tissue Repair in Savannah, GA for clinics & physicians. Growth factor therapy pr… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 23.5% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 13.6% of adults in Savannah have diagnosed diabetes — 1.6 points above the U.S. 12% figure. Together those PLACES numbers are why a city under 250k still needs separate PRP and CTP protocols. growth factor therapy inventory is national; utilization is JJ-local.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)CDC PLACES (2023, crude) estimates 13.6% of adults in Savannah have diagnosed diabetes — 1.6 points above the U.S. 12% figure. Adult obesity in Savannah is 34.5% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 23.5% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JJ / Palmetto GBA, sibling states AL, TN. Georgia Department of Public Health is the public-health home. We will not mash those grains into a fake “demand score.”
We are not going to invent a Savannah warehouse or a five-star local review. What you get is growth factor therapy from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JJ, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 13.6% of adults — 1.6 points above the U.S. 12% figure. Obesity is 34.5%; arthritis is 23.5%. That is place-level BRFSS modeling, not a clinic census and not a Savannah trial.
No. /kw pages explain distribution options. Protocol, privilege, and informed consent remain with the licensed Georgia clinician.
No. Hematogel is a PRP-based wound gel pathway with its own application and documentation. Skin substitutes/CTPs follow Palmetto GBA CTP articles. Mixing those codes is a billing error.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Georgia.
Ask for the IFU, the lot-traceability packet, and the Palmetto GBA article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Savannah fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Savannah, GA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Savannah is JJ geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Savannah — 1.6 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Georgia Part B wound biologics follow this contractor (siblings: AL, TN). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Savannah. Useful for joint-program math; still needs a diagnosis and privileging.
No Savannah storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.